Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6519072/global-latanoprost-2021-2027-470
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
Market Analysis and Insights: Global Latanoprost Market
In 2020, the global Latanoprost market size was US$ 1344.6 million and it is expected to reach US$ 1565.8 million by the end of 2027, with a CAGR of 2.2% during 2021-2027.
Global Latanoprost Scope and Market Size
Latanoprost market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Latanoprost market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.
Segment by Type, the Latanoprost market is segmented into
- Brand Drug
- Generic Drug
Segment by Application, the Latanoprost market is segmented into
- Open-angle Glaucoma
- Close-angle Glaucoma
Regional and Country-level Analysis:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Competitive Landscape and Latanoprost Market Share Analysis
Latanoprost market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Latanoprost product introduction, recent developments, Latanoprost sales by region, type, application and by sales channel.
The major companies include:
- Pfizer
- Mylan
- Novartis
- Apotex
- Teva
- Taj Pharma
- CR Zizhu
Reasons to Purchase Our Research Report:
- Analyzing the outlook of the market with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
- Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- Analyst support, along with the data support in excel format.
Get the Complete Report & TOC @ https://www.statsmarketresearch.com/global-latanoprost-2021-2027-470-6519072
Table of content
1 Study Coverage
1.1 Latanoprost Product Introduction
1.2 Market by Type
1.2.1 Global Latanoprost Market Size Growth Rate by Type
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Latanoprost Market Size Growth Rate by Application
1.3.2 Open-angle Glaucoma
1.3.3 Close-angle Glaucoma
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Latanoprost Market Size Estimates and Forecasts
2.1.1 Global Latanoprost Revenue 2016-2027
2.1.2 Global Latanoprost Sales 2016-2027
2.2 Latanoprost Market Size by Region: 2021 Versus 2027
2.3 Latanoprost Sales by Region (2016-2027)
2.3.1 Global Latanoprost Sales by Region: 2016-2021
2.3.2 Global Latanoprost Sales Forecast by Region (2022-2027)
2.3.3 Global Latanoprost Sales Market Share by Region (2016-2027)
2.4 Latanoprost Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Latanoprost Revenue by Region: 2016-2021
2.4.2 Global Latanoprost Revenue Forecast by Region (2022-2027)
2.4.3 Global Latanoprost Revenue Market Share by Region (2016-2027)
3 Global Latanoprost by Manufacturers
3.1 Global Top Latanoprost Manufacturers by Sales
3.1.1 Global Latanoprost Sales by Manufacturer (2016-2021)
3.1.2 Global Latanoprost Sales Market Share by Manufacturer (2016-2021)